Close Menu

NEW YORK ─ Ortho Clinical Diagnostics on Tuesday provided additional information on its plan to go public on the Nasdaq, saying it is offering 70 million ordinary shares at an initial public offering price expected to be between $20.00 and $23.00 per share, which would amount to between $1.4 billion and $1.61 billion in gross proceeds.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.